Gene expression in poorly differentiated papillary thyroid carcinomas
about
Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cellsThe potent Cdc7-Dbf4 (DDK) kinase inhibitor XL413 has limited activity in many cancer cell lines and discovery of potential new DDK inhibitor scaffoldsModulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicityDock10, a Cdc42 and Rac1 GEF, induces loss of elongation, filopodia, and ruffles in cervical cancer epithelial HeLa cellsGene expression profiling associated with the progression to poorly differentiated thyroid carcinomasOverexpressed Claudin-1 Can Be Visualized Endoscopically in Colonic Adenomas In Vivo.Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas.Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivoDifferent gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.Periostin is up-regulated in high grade and high stage prostate cancer.Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion.High expression of periostin is dramatically associated with metastatic potential and poor prognosis of patients with osteosarcoma.Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone miceNotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells.The claudin family of proteins in human malignancy: a clinical perspectiveThe Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma.Thyroid tumors: novel insights from proteomic studies.Overexpression of periostin is significantly correlated to the tumor angiogenesis and poor prognosis in patients with esophageal squamous cell carcinomaClinical implications of molecular markers in follicular cell-derived thyroid cancer.Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation.Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration.Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.New Insights in Thyroid Cancer and p53 Family Proteins.The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.Novel isoforms of periostin expressed in the human thyroid.Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer.Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation.RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation.LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma.Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.Heterogeneous Periostin Expression in Different Histological Variants of Papillary Thyroid Carcinoma.
P2860
Q24642524-20929907-A2D3-4602-9062-7513EA772720Q28545089-CB66CE9C-EA9C-4388-8DF4-A2892E4B9695Q28571256-46278DB9-A20A-407A-96F0-7390D9F5F633Q30384805-B5BF25CC-1F0B-467B-9CFB-DBAAA770E03DQ30491720-7E59A936-6776-4C85-9D68-9AF72365826CQ30797702-4EA2E998-C71B-4D28-8C17-548497284ACCQ30962468-A59F6FEA-6F27-44C4-9664-BE1BB4B2A90CQ33317065-B1C57A55-55B9-4D39-986A-2E0AF2303102Q33371410-043E4CB3-839B-4506-9AAA-C2CDDB50D840Q33599377-A65ABC62-8E63-4848-ADB4-24C208B10BCCQ33728232-AFC932A7-7F10-4B91-A0D2-9E1C61C33A4AQ34405669-C355BF43-CBB8-4CBD-AAEB-5FC7A3C1C136Q34519639-7F56F196-CC5C-4517-BBA7-383A72F5D1AEQ34586512-E1A81C11-D6B8-4EEF-A2E4-CB85309D6C3DQ34733218-EED00A22-C189-4B53-86AB-FC290DECF825Q35563909-18C0E2D5-96C2-439A-A04F-FBE6EC453BB6Q36396570-0FF8AFC5-2A77-4F34-80B8-94CE3507DC90Q37087086-EAC5894F-BAF4-4D0D-A315-6068550B1A98Q37302556-6E4FC554-6762-496E-B5A5-812213632E41Q37381782-D94DB1ED-4EE0-4A37-83B1-B7EC7B112409Q37579897-0590D0F5-9A5B-46DE-8A26-C2C06C0455D2Q37587354-1DE525B7-F6FE-4AB7-97F6-538E96B92EF9Q37611825-E134F790-5A75-48FB-93DB-8967D7BB61E5Q37702322-559C4E38-0D8D-4F11-BA9F-B6B2590C1F2CQ38979602-E9A3BA66-3E13-4DC1-AC10-CAC096FED0F4Q39377477-525A93A7-4806-4C2E-8026-7FDDCC744C08Q39381923-D5F1EB20-87E2-4DD7-A169-D91862388A44Q39387810-7B505030-676A-4DF9-BCA6-6F49B43DC3C6Q39492314-2E933DE5-3F4E-4290-8B6C-DAFC2740B2E0Q39575018-393D7C13-2B3E-4FAC-AA67-9EAB0F8F4809Q42105368-4E136E9D-5756-49D6-B00A-A017215BA6B4Q42326115-B2A90A33-AD4E-4614-B34A-FD9C024A71D3Q42759235-DA912737-7A43-4692-9080-F36EBE5D86E7Q42809152-58E480D0-DBCE-49DE-B5E0-EEACB3A1B232Q43641188-A4540667-A024-4D1B-A7EE-528FBB9E41FDQ44627185-DF014ADD-8D98-4090-A1CC-C3C24AA5F0ACQ47247138-AAA264E9-84B2-4450-84D3-3AC79D964D4AQ47393027-53534FF9-CB34-4C9E-AFDD-1B14025E5E71Q47691203-D7CC5CA7-EFEB-4532-9FD3-C2D7301394A7Q49525318-6CA95B79-B3BE-4619-90E3-C7D2FAF99477
P2860
Gene expression in poorly differentiated papillary thyroid carcinomas
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gene expression in poorly differentiated papillary thyroid carcinomas
@ast
Gene expression in poorly differentiated papillary thyroid carcinomas
@en
Gene expression in poorly differentiated papillary thyroid carcinomas
@nl
type
label
Gene expression in poorly differentiated papillary thyroid carcinomas
@ast
Gene expression in poorly differentiated papillary thyroid carcinomas
@en
Gene expression in poorly differentiated papillary thyroid carcinomas
@nl
prefLabel
Gene expression in poorly differentiated papillary thyroid carcinomas
@ast
Gene expression in poorly differentiated papillary thyroid carcinomas
@en
Gene expression in poorly differentiated papillary thyroid carcinomas
@nl
P50
P3181
P356
P1433
P1476
Gene expression in poorly differentiated papillary thyroid carcinomas
@en
P2093
Johan R Lillehaug
Ove Bruland
P304
P3181
P356
10.1089/THY.2006.16.161
P407
P577
2006-02-01T00:00:00Z